Every private equity firm that calls you already knows what your company is worth, roughly, before they ever get on the phone. You don't. That asymmetry is the whole game - and it's fixable in an afternoon.
The valuation methodology PE firms use isn't secret or complicated. It's a repeatable process: start with EBITDA, normalize it, apply a market multiple, and sanity-check the result against comparable deals. Run that same process on your own numbers before you're sitting across from a fund's analyst, and you walk into every conversation - private equity, strategic buyer, or Independent Buyout - knowing your number instead of accepting theirs.
Step 1: Start with EBITDA, not revenue
Private equity firms almost universally price deals off EBITDA - earnings before interest, taxes, depreciation, and amortization - because it strips out financing and accounting choices and shows the cash-generating power of the business itself (Corporate Finance Institute). Revenue tells a buyer how big you are. EBITDA tells them how much cash the business actually throws off, which is what services the acquisition debt a sponsor places on your balance sheet and generates their returns.
Step 2: Normalize it - this is where most of the value gets found or lost
Your reported EBITDA is not what a buyer will pay a multiple against. Buyers start with reported EBITDA, then adjust for one-time items and owner-specific costs to arrive at "adjusted" or "normalized" EBITDA - the number the deal actually prices on (Lutz).
Common add-backs include: - Above-market owner compensation. If you pay yourself more than a market-rate professional manager would cost to run the business, the difference is added back (Shepi.ai). - One-time or non-recurring expenses - legal settlements, a one-off equipment failure, transaction costs. - Discretionary or personal expenses run through the business.
This isn't a minor technicality. At a typical lower-middle-market multiple, every $100,000 of successfully defended add-back can translate into $400,000-$700,000 of additional enterprise value - and every add-back a buyer's diligence team rejects gets removed at that same ratio, straight out of your price (Glacier Lake Partners). Owner compensation is the single most commonly challenged add-back in diligence - sellers who lowball the "replacement cost" of their own role routinely give value back at the table (Glacier Lake Partners).
The playbook move here: build your add-back schedule before a buyer's team builds theirs. Know which of your adjustments are genuinely defensible - one-time transaction costs, duplicative compensation, discontinued-operation costs - and which are softer, so nothing in your number surprises you mid-negotiation (LinkedIn / Matteo Chiappini on QoE add-back categories).
Step 3: Get a Quality of Earnings review done on your own terms, first
A Quality of Earnings (QoE) report reconciles your reported EBITDA to what a buyer will consider "true," maintainable EBITDA - stripping out one-time items and stress-testing your add-backs before a deal ever prices (Eternal PE). It is not the same as an audit: an audit asks whether your historical numbers are accurate; a QoE asks whether your earnings are sustainable and actually convert to cash going forward (Human R). That distinction - sustainable, cash-converting earnings - is exactly what a buyer's investment committee is pricing.
Aggressive add-backs are running at an average of 29.4% of management-adjusted EBITDA industry-wide, and diligence teams are rejecting more of them than they used to (Human R, "15 EBITDA Add-Backs PE Firms Accept," 2026 guide). Commission your own QoE before you go to market, and you fix the soft spots in your own numbers while you still control the timeline - instead of finding them out during a live negotiation, when they become the buyer's leverage against you. The lead time is the point: a QoE is worth commissioning a year or two before the data room opens, which is why it sits early in the sequence in exit planning for business owners rather than in the deal itself.
Step 4: Apply the market multiple
Once you have a defensible, normalized EBITDA figure, the buyer applies a multiple derived from recent comparable deals - this is where "comps" come in. Two related methods drive the multiple:
- Comparable company analysis looks at the trading or transaction multiples of similar businesses.
- Precedent transaction analysis looks specifically at what buyers actually paid in recent M&A deals for similar companies - and typically runs 15-30% higher than public trading comps, because it captures the control premium a buyer pays to actually own and direct the business, not just hold shares in it (CT Acquisitions).
As of 2025, average lower-middle-market EBITDA multiples held at roughly 7.2x across deals in the $10 million-$500 million enterprise value range, according to GF Data - with meaningful spread by sector: healthcare services near 8.3-8.5x, business services around 7.2-7.4x, manufacturing closer to 6.5-7.0x (CIBC US Middle Market Monitor, Q1 2026; Mid Market Advisory). Those averages hide as much as they show, because sector dynamics do the real work: healthcare services M&A and restaurant M&A price on different logic even at identical EBITDA, and in government contractor M&A the contract type matters as much as the multiple, because a cost-plus base changes what an acquisition can afford to carry. Each of those three now has its own valuation breakdown - restaurants, healthcare services and government contractors - covering the mechanics that move each band. Size matters too - deals around $20 million in enterprise value have cleared closer to 6.4x, while $150 million deals have cleared closer to 10x (Capital Pad). Those averages sit above what a $3-5M-EBITDA company should expect, precisely because the population behind them skews larger; our EBITDA multiples by industry reference publishes ranges calibrated to that smaller size, and the size adjustment between the two. If you don't know where your sector and size actually sit in that range, you have no way to know if a buyer's opening number is fair or lowball. The business valuation calculator puts a sector-adjusted range around your own EBITDA in a couple of minutes.
The math, in one table
| Step | What it is | Why it moves your price |
|---|---|---|
| Reported EBITDA | Your P&L's current earnings figure | The unadjusted starting point - not the sale price |
| Normalized EBITDA | Reported EBITDA + defensible add-backs | Every $100K of defended add-back ≈ $400K-$700K of enterprise value at typical LMM multiples (Glacier Lake Partners) |
| Quality of Earnings review | Independent test of whether normalized EBITDA is sustainable | Determines how much of your add-back schedule actually survives diligence (Human R) |
| Market multiple (comps) | Sector/size-adjusted multiple from recent deals | 2025 lower-middle-market average ~7.2x EBITDA, varying by sector and size (CIBC) |
| Enterprise value | Normalized EBITDA × multiple | This is the number a term sheet is actually built around |
This table is illustrative - actual multiples and outcomes vary by transaction, sector, and specific deal facts.
Step 5: Bridge enterprise value to the cash you actually receive
This is the step most valuation write-ups skip, and it is where sellers get the largest surprise. Enterprise value is not a wire transfer. Lower-middle-market deals are almost always written on a "cash-free, debt-free" basis: the buyer subtracts your funded debt, adds back your cash, and then makes a separate adjustment for working capital before anything reaches your account.
The working capital adjustment is the one worth learning cold. The purchase agreement sets a target - the "peg" - typically calculated as a trailing 6- or 12-month average of normalized net working capital, adjusted for one-time anomalies such as an unusual customer prepayment or a stretched vendor payment (Schneider Downs). Receivables, inventory, and prepaids are in; cash, the revolver, and accrued interest are excluded as financing items (BDO). If the working capital you deliver at close lands below the peg, the shortfall reduces the purchase price dollar for dollar; if it lands above, the excess is additional purchase price that belongs to you (Schneider Downs).
Two things make this asymmetric. First, the true-up is calculated 60 to 90 days after closing, so the final figure arrives months after you have signed and stopped negotiating (Schneider Downs). Second, the buyer wants the highest peg it can defend and you want the lowest, and the buyer's diligence team does that analysis full-time while you are still running the company (BDO).
A worked example - invented numbers, real arithmetic
| Line | Amount |
|---|---|
| Normalized EBITDA | $4.0M |
| Market multiple | 7.0x |
| Enterprise value | $28.0M |
| Less funded debt and capital leases | -$5.5M |
| Plus cash on the balance sheet | +$0.8M |
| Working capital delivered ($2.6M) against a $3.1M peg | -$0.5M |
| Escrow / indemnity holdback, released 12-24 months after close | -$2.3M |
| Transaction fees - advisory, legal, QoE, insurance | -$1.1M |
| Cash wired to the seller at close | $19.4M |
Same 7.0x multiple, same $28 million headline - and roughly 69 cents on the dollar of it moves at close, with the escrow and the working capital true-up still unresolved. These figures are invented to show the arithmetic, not offered as a benchmark; your own debt balance, working capital cycle, and fee load will produce a different bridge. Build yours before you argue about the multiple, because half a turn of multiple is often worth less than a well-defended working capital peg - and a sponsor that funds the purchase with debt placed on your company has a direct interest in how much liquidity it leaves behind at close.
Why this same playbook applies to an Independent Buyout
Owners are usually shown two paths for a sale conversation: private equity or a strategic buyer. Both price the deal using exactly the methodology above - normalized EBITDA times a market multiple. What most owners aren't told is that an Independent Buyout, where the company's own leadership team becomes the buyer, is priced the same way. The valuation work doesn't change; what changes is who's on the other side of the table, who finances the purchase, and what happens to control after close. Those differences are worth seeing in dollars - the side-by-side numbers comparison runs the same headline multiple through both structures.
The same is true of every other route out. A management buyout, a minority recapitalization, and an internal transition all price off normalized EBITDA and a market multiple. Identical arithmetic does not produce an identical number, though: a management team and a private equity sponsor bidding on the same company clear at roughly 4x-6x and 6.4x-8.3x respectively, and that gap is funding capacity rather than valuation method. Which is why the valuation work is worth doing once and reusing across the alternatives to selling to private equity - and why owners weighing a family or internal succession still need a defensible number before they can decide what the business can afford to pay them.
Enterprise value is also only half the picture. In a sponsor deal a slice of the agreed price comes straight back as rollover equity you can't spend, so the multiple you negotiate and the cash you actually receive at close are two different numbers.
Running your own EBITDA normalization and comp analysis before any conversation means you show up to a private equity pitch, a strategic buyer's diligence team, or an Independent Buyout structuring conversation already knowing your number - instead of hearing it for the first time from someone whose fund is compensated by getting you to accept less of it, or a broker whose fee only exists if that specific type of deal closes.
Frequently asked questions
Why do private equity firms use EBITDA instead of revenue or net income? EBITDA strips out financing structure, tax situation, and non-cash accounting choices, isolating the cash-generating power of operations - which is what a leveraged buyer actually cares about servicing debt against (Corporate Finance Institute).
What's the single biggest lever an owner controls in their own valuation? The add-back schedule, particularly owner compensation normalization. Building and defending it correctly before a buyer's diligence team builds their own version of it can meaningfully change your final number (Glacier Lake Partners).
Is a Quality of Earnings report the same as an audit? No. An audit verifies historical accuracy under accounting rules. A QoE tests whether your earnings are sustainable and convert to cash going forward - the actual question a buyer's price is based on (Human R).
Do private equity buyers and Independent Buyout structures value a company differently? No - both price off normalized EBITDA and a market-based multiple. The valuation methodology is the same; what differs is the buyer, the financing source, and what happens to control and tax treatment after close.
Is enterprise value the same as what I get paid? No. Enterprise value is normalized EBITDA times a multiple. What reaches your account at close is that figure less funded debt, plus cash, adjusted against the working capital peg, less escrow and transaction fees - and the working capital piece is trued up 60 to 90 days after closing (Schneider Downs).
What is a working capital peg? A target level of net working capital - receivables, inventory, and prepaids, excluding cash and the revolver - usually set from a trailing 6- or 12-month normalized average. Deliver less than the peg at close and the purchase price drops dollar for dollar; deliver more and the excess is yours (BDO).
What EBITDA multiple should I expect for my business? It depends heavily on sector and size. Lower-middle-market deals averaged roughly 7.2x EBITDA in 2025, with healthcare services trading near 8.3x-8.5x and manufacturing closer to 6.5x-7.0x, and larger deals commanding higher multiples than smaller ones (CIBC Q1 2026; Mid Market Advisory).
Sources
- Corporate Finance Institute - "EBITDA Multiple"
- Lutz - "Understanding EBITDA and Normalizing Adjustments"
- Shepi.ai - "Owner Compensation Normalization"
- Glacier Lake Partners - "EBITDA Normalization Add-Backs Deep Dive"
- Eternal PE - "Quality of Earnings"
- Human R - "Quality of Earnings vs. Audit: M&A Due Diligence Guide"
- Human R - "15 EBITDA Add-Backs PE Firms Accept, 2026 Guide"
- CT Acquisitions - "Relative Valuation: Comparable Companies for Business, 2026"
- CIBC US Middle Market Monitor, Q1 2026
- Mid Market Advisory - "EBITDA Multiples by Industry"
- Capital Pad - "Lower Middle Market EBITDA Multiples"
- Schneider Downs - "Understanding the Net Working Capital Peg in M&A Transactions"
- BDO - "Net Working Capital Is Vital in M&A"
The bottom line
Private equity firms don't have a secret formula. They have a repeatable process - normalize your EBITDA, apply a defensible market multiple, stress-test it with a Quality of Earnings review - and they run it on your business whether you've run it yourself or not. The only question is whether you know your own number before you sit down, or find it out from someone who's paid more when you accept a lower one.
If your company is doing $3M+ in EBITDA and you want a real read on your number before any sale conversation - private equity, strategic, or an Independent Buyout - talk to IBO Advisors about your specific business.
Curious whether an Independent Buyout fits your business?
Learn More